| Literature DB >> 20014466 |
Allison-M Quick1, Mark Bloomston, Edward-Y Kim, Nathan-C Hall, Nina-A Mayr.
Abstract
The incidence of hepatocellular carcinoma (HCC) is increasing in the United States, and 50%-75% of patients with HCC will develop metastatic disease. Orbital metastases from HCC are extremely rare. We report the case of a 52-year-old male with known metastatic HCC, who presented with severe proptosis and diplopia. An orbital mass was identified on magnetic resonance imaging (MRI) and confirmed to have hypermetabolic activity on positron emission tomography/computed tomography. He received a palliative course of external beam radiation therapy to the right orbit. Intensity modulated radiation therapy (IMRT) was used to allow sparing of critical normal tissues in close proximity to the tumor. One month after completion of IMRT to 58 Gray in 30 fractions delivered over 6 wk, the patient had a complete clinical, radiologic (MRI) and symptomatic response. The patient continues to have local control in the orbit 1.7 years after therapy completion. All critical normal structures were kept below the tolerance dose using IMRT, and no toxicities were observed.Entities:
Keywords: Eye neoplasms; Hepatocellular carcinoma; Intensity modulated radiation therapy; Metastasis; Palliative therapy
Mesh:
Year: 2009 PMID: 20014466 PMCID: PMC2795189 DOI: 10.3748/wjg.15.6000
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.742